A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
A Phase 1/2, Randomized, Observer-Blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Vaccine Candidates Against Influenza and COVID-19 in Healthy Individuals
Category & Conditions: Respiratory Disease
Medicine: Combination COVID-19 and Influenza modRNA Vaccine (PF-07926307)
ClinicalTrials.gov Identifier (NCT): NCT06683352
Protocol ID: C5261023
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here